Skip to content

STING & TLR Targeting Therapies

Calendar icon to

Speakers

Gyongyi Szabo

Chief Academic Officer - BILH and BIDMC

Ulrike Gnad-Vogt

Senior VP Oncology & Translational Medicine, Chief Development Officer ad interim - CureVac

Chris Winter

Chief of Research & Development - Silicon Therapeutics

Jim Eyles

Associate Director - AstraZeneca

Yuxiao Wang

Senior Director - Discovery Research - Myeloid Therapeutics

Kader Thiam

Senior Vice President - Discovery, Preclinical Models & Services - GenOway

Bonnie Phillips

Associate Director, Translational Applications - Nilogen Oncosystems

Alex Stevenson

Chief Scientific Officer - 4D Pharma PLC

Woody Sherman

Chief Computational Scientist - Silicon Therapeutics

Tatiana Novobrantseva

Chief Scientific Officer, Co-founder & Head of Research & Development - Verseau Therapeutics

Sebastian Carotta

Director - Cancer Research & Scientific - Boehringer Ingelheim

Sean Lawler

Associate Professor - Harvard Medical School

Robert Andtbacka

Chief Medical Officer - Seven and Eight Biopharmaceuticals Inc.

Nicolas Manel

Principal Investigator - Institut Curie

Naniye Cetinbas

Senior Scientist - Cancer Immunotherapy Drug Discovery - Mersana Therapeutics

Michael Newman

President and CEO - Decoy Biosystems

Martin Jakobsen

Chief Scientific Officer - STipe Therapeutics

Lena Horvath

M.D. - Innsbruck Medical University

Laura Glickman

Vice President - Research & Cofounder - Actym Therapeutics

Kyriakos Economides

Director - Pharmacology - Codiak Biosciences

Krzysztof Brzozka

Chief Scientific Officer & Executive Vice President - Ryvu Therapeutics

Kimmy Kin-Mei Leung

Project Leader - F-star Biotechnology Ltd.

Joshi Ramanjulu

Senior Director & Head of Project Leader Group, Innate Immunity Research Unit - GlaxoSmithKline

Johannes Grosse

Senior Director - Drug Discovery - Vir Biotechnology Inc.

Joachim Koch

Head of Translational Research & Innovation - Affimed GmbH

Jeremy Duvall

Director - Mersana Therapeutics

James Appleman

CSO, Co-founder, Director & Senior VP - Research & Development - Primmune Therapeutics, Inc.

Hong Wan

President & CEO - Tallac Therapeutics

Geoffrey Lynn

Chief Executive Officer - Avidea Technologies

Diwaker Davar MD

Assistant Professor - Phase, Therapeutics & Melanoma - University of Pittsburgh

David Hava

Chief Scientific Officer - Synlogic

Adi Diab

Associate Professor - Melanoma Medical Oncology - MD Anderson Cancer Center

James Wooldridge, MD

Chief Medical Officer - Checkmate Pharmaceuticals

Arthur Krieg

Founder, Chief Scientific Officer & Chief Executive Officer - Checkmate Pharmaceuticals

Xingfeng Bao

Senior Director - H3 Biomedicine

Andrew Miller

Co-founder & Vice President - Immunology & Operations - Apros Therapeutics Inc.

Bettina Werle

CSO - Tollys

Bob Uger

Chief Scientific Officer - Trillium Therapeutics Inc

Edith A Perez, MD

Chief Medical Officer - Bolt Biotherapeutics

John Flygare

Senior Principal Scientist - Merck & Co

Kate Fitzgerald

Professor - UMass Medical School

Marc Damelin

Vice President, Biology - Mersana Therapeutics

Nicholas Huntington

Co-Founder & Chief Scientific Officer - oNKo-innate

Shannon Morris

Vice President of Clinical Development - Istari Oncology Inc.

Sonia Macia

Medical Director - Highlight Therapeutics SL

The event is over

Hosted by

Hanson Wade

Hanson Wade builds world leading conferences and data products in high growth industries.

Booths

4D pharma plc

Developing Science, Delivering Therapies

Nilogen

Make better decisions for your translational immune-oncology program with the most clinically-relevant 3D cancer model – 3D-EXplore

genOway

.

IntoDNA

Where DNA breaks, our insight begins

LinkedIn Drop

Connect with your peers while onsite!